Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

A first for Bluebird and Europe as gene therapy Zynteglo approved

Will product be priced over $1m?

- PMLiVE

Rival Novartis, Merck drugs square up on rare lung cancer at ASCO

An inflection point for MET-inhibitor class

- PMLiVE

Marrying scientific rigour with creative vigour

By Andrew Croskery

- PMLiVE

AZ reports stellar results for Lynparza in pancreatic cancer

Plans to file as soon as possible

- PMLiVE

Encouraging early data for Amgen’s BiTE therapies

Including first-in-man data from prostate cancer drug

Lumentium

Apex launches new immersive gastronomic event experience in the pharma sector

Specialist pharmaceutical conference and event management company Apex has launched the ultimate immersive gastronomic experience in the UK and global events market.

Apex Events and Exhibitions

- PMLiVE

Hancock says “NHS not for sale” in post-Brexit US trade talks

Tensions rise as President Trump arrives for state visit

- PMLiVE

The rise of CEO activism

By Emma Knott

Roche Basel Switzerland

Roche/GE’s digital medicine alliance bears first fruit

While new player enters liquid biopsy market

- PMLiVE

Biogen trumpets safety data for Tecfidera follow-up

Much riding on blockbuster's successor

- PMLiVE

Vertex makes choice for all-important CF triple therapy

Promises to treat up to 90% of CF patients

Precision medicine from concept to clinic

In our latest edition of ‘Perspective’ magazine, we examine the challenges and opportunities for several stakeholders impacted by the dawn of precision medicine

Blue Latitude Health

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links